Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $39.4 million, a decline of 17.3% from Q1 2024, with adjusted EBITDA at $3.8 million and a margin of 9.5%, down from $7.3 million and 15.4% in the prior year [7][21][25] - Same store revenue decreased approximately 24% year-over-year, consistent with expectations [9][21] - Average revenue per case was $12,799, slightly higher than the previous year [21] Business Line Data and Key Metrics Changes - The decline in revenue was primarily driven by lower case volumes, with cases down 17.9% to 3,070 [21] - Cost of service decreased by $2.1 million compared to the prior year, but as a percentage of revenue increased to 40.5% from 37.9% due to fixed costs [22][23] - Customer acquisition cost rose to $3,130 per case from $2,990 in the prior year, driven by decreased case volumes [25] Market Data and Key Metrics Changes - The percentage of patients using financing for procedures was 44%, down from 50% in the previous quarter [22] - The company operates in a challenging macroeconomic environment, impacting consumer spending and case volumes [6][19] Company Strategy and Development Direction - The company is focused on stabilizing performance and laying the foundation for long-term growth, with a strategic emphasis on cost discipline, marketing efficiency, and operational rigor [6][7] - New marketing strategies have been implemented, reallocating spend to effective channels such as search engine marketing and social media [15][46] - A pilot for a new skin tightening procedure is being launched, expected to broaden consumer reach and create a new revenue stream [16] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the softening consumer environment and internal challenges but remains confident in the steps taken to reposition the business for sustained success [6][19] - The company expects fiscal 2025 revenue in the range of $160 million to $170 million and adjusted EBITDA between $16 million and $18 million, reflecting current economic conditions [18][27] - Management is closely monitoring consumer behavior and inflationary pressures, which could impact discretionary spending [19] Other Important Information - The company is committed to reducing leverage to historical levels and is in compliance with all covenants under its credit agreement [26] - Cash flow from operations for the quarter was $900,000, down from $3.4 million in the prior year [27] Q&A Session Summary Question: Can you speak to some of the specific cost savings that you saw in the quarter? - Management noted significant cost savings from workforce changes, targeting $3 million in savings for the year [30] Question: What is the potential margin you think you can achieve on $160 million to $170 million of revenues? - Management expects to approach long-term EBITDA margins of around 30% as revenue trends improve [32] Question: Have you seen any improvement in the rate of conversion to cases? - Management indicated that the time to book cases remains elongated due to macroeconomic pressures, but lead volumes are growing [40] Question: What does the low end versus the high end of your guidance assume for the current macro? - The low end assumes further moderation in consumer spending, while the high end incorporates benefits from new initiatives [52] Question: When will the new financing options roll out? - The rollout is expected by the end of Q2, aimed at providing consumers with more flexible payment options [56]